Product information and disease descriptionProduct descriptionProduct informationDosing and administration
Dosage
4 evidence topics · 5 sources
ARCHER II: 5.0 mg per eye monthly for 24 months
ARCHER: 5 mg monthly or every other month for 12 months
Open-label extension: monthly dosing for 24 months
Dose selection: aqueous humor target engagement in phase 1
Proposed labeled dose, dosing interval, and dose modification
No evidence found.